Tenet Healthcare Corporation $THC Stock Holdings Trimmed by Shell Asset Management Co.

Shell Asset Management Co. lessened its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 57.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,709 shares of the company’s stock after selling 3,702 shares during the period. Shell Asset Management Co.’s holdings in Tenet Healthcare were worth $550,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. ProShare Advisors LLC increased its stake in Tenet Healthcare by 1.7% during the second quarter. ProShare Advisors LLC now owns 4,118 shares of the company’s stock valued at $725,000 after purchasing an additional 67 shares during the last quarter. Quadcap Wealth Management LLC grew its position in shares of Tenet Healthcare by 1.7% during the 2nd quarter. Quadcap Wealth Management LLC now owns 4,099 shares of the company’s stock valued at $721,000 after buying an additional 69 shares during the last quarter. Andina Capital Management LLC lifted its holdings in Tenet Healthcare by 2.1% in the third quarter. Andina Capital Management LLC now owns 3,360 shares of the company’s stock worth $682,000 after acquiring an additional 69 shares during the last quarter. Assetmark Inc. boosted its stake in Tenet Healthcare by 0.9% in the second quarter. Assetmark Inc. now owns 8,709 shares of the company’s stock valued at $1,533,000 after acquiring an additional 76 shares during the period. Finally, MGO One Seven LLC raised its position in shares of Tenet Healthcare by 3.8% during the 3rd quarter. MGO One Seven LLC now owns 2,231 shares of the company’s stock worth $453,000 after purchasing an additional 82 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director owned 28,480 shares of the company’s stock, valued at $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.81% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on THC. Barclays raised their target price on Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research note on Friday. Wells Fargo & Company reaffirmed an “overweight” rating and set a $265.00 price target on shares of Tenet Healthcare in a research note on Monday. Guggenheim boosted their target price on shares of Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a report on Friday. Raymond James Financial set a $245.00 target price on Tenet Healthcare in a report on Wednesday, October 29th. Finally, Jefferies Financial Group raised their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $246.71.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $234.37 on Wednesday. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The stock has a market capitalization of $20.60 billion, a P/E ratio of 15.13, a P/E/G ratio of 0.96 and a beta of 1.44. The business has a 50-day moving average of $199.97 and a two-hundred day moving average of $196.22. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $235.77.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same period in the previous year, the company earned $3.44 EPS. The company’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities research analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.